 Human T-cell leukemia virus type oncogenic prognostic risk factor cervical vaginal carcinoma seroprevalence human T-cell leukemia virus type HTLV-I antibody healthy females women gynecologic malignancies living adult T-cell leukemia-endemic area southwestern Japan HTLV-I infection risk factor oncogenesis prognosis seroprevalences cervical carcinoma patients years vaginal carcinoma patients ages age-matched healthy controls ratios observed HTLV-I seroprevalence patients cervical carcinoma vaginal carcinoma patients patients cervical carcinoma vaginal carcinoma tumor recurrence rate HTLV-I carriers HTLV-I seronegative patients results HTLV-I infection oncogenic prognosis patients cervical vaginal carcinoma